Articles & courses

Articles
Incretins in Cardiometabolic Medicine: Leveraging GLP-1, GIP, and Glucagon Receptor Agonism for Cardiovascular Risk Reduction

…of incretin based therapies, starting with glucagon like peptide 1 receptor agonists (GLP 1 RAs) and evolving into multi receptor agonists, has unleashed a new…

Media

No matches.

Tests

Tools